Eli Lilly reached a historic milestone on Friday when it briefly surpassed a $1 trillion market capitalization, becoming the first health-care company in the world to enter a territory long dominated by technology giants. The company’s stock hovered near $1,048 per share during morning trading, touching the trillion-dollar threshold before pulling back slightly. It is only the second nontechnology business in the United States to reach this valuation, following Berkshire Hathaway’s climb
Eli Lilly reached a historic milestone on Friday when it briefly surpassed a $1 trillion market capitalization, becoming the first health-care company in the world to enter a territory long dominated by technology giants. The company’s stock hovered near $1,048 per share during morning trading, touching the trillion-dollar threshold before pulling back slightly. It is only the second nontechnology business in the United States to reach this valuation, following Berkshire Hathaway’s climb
A senior pharmaceutical executive collapsed during an Oval Office event where former U.S. President Donald Trump was announcing a new initiative to reduce the prices of obesity drugs. The incident caused a sudden interruption to the live broadcast of the announcement, which was centered on a major agreement between the Trump administration and leading pharmaceutical manufacturers. According to eyewitnesses, the executive, later identified as Gordon Findlay of Novo Nordisk, lost his
A senior pharmaceutical executive collapsed during an Oval Office event where former U.S. President Donald Trump was announcing a new initiative to reduce the prices of obesity drugs. The incident caused a sudden interruption to the live broadcast of the announcement, which was centered on a major agreement between the Trump administration and leading pharmaceutical manufacturers. According to eyewitnesses, the executive, later identified as Gordon Findlay of Novo Nordisk, lost his